DETERMINATION OF OFLOXACIN, A NEW OXAZINE DERIVATIVE IN HUMAN-SERUM, URINE, AND BILE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引：22

作者：

CARLUCCI, G

GUADAGNI, S

PALUMBO, G

机构：

[1] UNIV AQUILA,DEPT SURG CLIN,I-67100 AQUILA,ITALY

[2] UNIV AQUILA,DEPT INTERNAL MED & PUBL HLTH,CHAIR PHARMACOL,I-67100 AQUILA,ITALY

来源：

JOURNAL OF LIQUID CHROMATOGRAPHY | 1986年 / 9卷 / 11期

关键词：

D O I：

10.1080/01483918608076882

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：2539 / 2547

页数：9

共 9 条

[1] [Anonymous], 1984, CHEMOTHERAPY, V32, P118
[2] GUADAGNI S, 1985, EUR REV MED PHARM SC, V7, P111
[3] MIDORI T, 1984, CHEMOTHERAPY TOKYO, V32, P59
[4] INVITRO AND INVIVO ACTIVITY OF DL-8280, A NEW OXAZINE DERIVATIVE
SATO, K
MATSUURA, Y
INOUE, M
UNE, T
OSADA, Y
OGAWA, H
MITSUHASHI, S
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) : 548 - 553
[5] COMPARISON OF THE ANTI-BACTERIAL INVITRO AND INVIVO ACTIVITY OF OFLOXACIN (HOE-280 DL-8280) AND NALIDIXIC-ACID ANALOGS
SEIBERT, G
LIMBERT, M
KLESEL, N
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (06) : 548 - 553
[6] Sudo K, 1984, CHEMOTHERAPY TOKY S1, V32, P1203
[7] TAKESHI N, 1984, CHEMOTHERAPY TOKYO, V32, P62
[8] VONSEIBERT G, 1984, ARZNEIM FORSCH DRUG, V34, P1552
[9] YASAKI O, 1984, CHEMOTHERAPY TOKYO, V32, P90